CRL Charles River: שווי עסקי להכנסות

Charles River Laboratories International, Inc. (CRL) - לוגו תאגידי

Charles River Laboratories (CRL) is integrating AI modeling into preclinical molecule discovery, strengthening its technological foundation. The EV/Sales trajectory illustrates the market valuation relative to revenue, where the parameter has stabilized at 4623.29. The brand's impeccable authority ensures institutional loyalty, although a reduction in biotech funding and pressure from animal rights activists create certain risks for long-term demand for the company's services.

Charles River (CRL) - מכפיל EV/Sales מ-23.11.2025 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Charles River Lab (CRL)

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
ניתוח ראשוני של החברה:Charles River Laboratories CRL
מוצר מקורי של Charles River Laboratories International, Inc.

This indicator compares the total enterprise value, including debt, to annual turnover, determining the market value of each unit of revenue. The EV/Sales ratio trend reflects the sensitivity of the Charles River Laboratories (CRL) valuation to geopolitical risks, where disruptions in cross-border biomaterial supplies and clinical trial delays could lead to a downward revision of the multiple due to declining operational efficiency.